The FDA, bridging data, and hepatitis C


  • See Articles on Pages 897 and 903.

  • Potential conflicts of interest: Dr. Fried Serves as ad hoc consultant to Genentech/Roche, Vertex, Merck, Gilead, BristolMyers Squibb, Abbott, Janssen. He receives research grants from Genentech/Roche, Vertex, Merck, Janssen, Gilead, BristolMyers Squibb, Rottapharm/Madaus. Dr. Jensen serves as ad hoc consultant to Abbott, Astex, Biotica, Boehringer-Ingelheim, BristolMyers Squibb, Genentech/Roche, Janssen, Gilead, Merck, and Vertex.

No abstract is available for this article.